Publications

The 340B Drug Pricing Program at a Crossroads.

JAMA
Knox RP, Sarpatwari A.

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials.

Drug Saf
Chimonas S, Cosenza C, Kesselheim AS, Toyserkani GA, Oswell KH, LaCivita C, Dal Pan GJ, Sarpatwari A.

Physician Awareness of FDA's Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic.

Drug Saf
Hwang CS, Lu Z, Russo M, Zakoul H, Toyserkani GA, Zhou EH, LaCivita C, Dal Pan GJ, Kesselheim AS, Sarpatwari A.

Risk of neutropenia-related hospitalisation among clozapine initiators

BMJ Ment Health.
Sarpatwari A, Mahesri M, Lii J, Lee SB, Zakoul H, Toyserkani GA, Zhou EH, Lacivita C, Dal Pan GJ, Bykov K, Moran L, Avorn J, Kesselheim AS, Huybrechts KF.

Physician Awareness of FDA's Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic

Drug Saf.
Hwang CS, Lu Z, Russo M, Zakoul H, Toyserkani GA, Zhou EH, LaCivita C, Dal Pan GJ, Kesselheim AS, Sarpatwari A.

Patient Perceptions of and Experiences with Risk Evaluation and Mitigation Strategies

Clin Pharmacol Ther.
Sarpatwari A, Lee SB, Zakoul H, Tekle W, Freedman A, Belitkar S, Toyserkani GA, LaCivita C, Zhou EH, Oswell KH, Dal Pan GJ, Kesselheim AS.

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials

Drug Saf.
Chimonas S, Cosenza C, Kesselheim AS, Toyserkani GA, Oswell KH, LaCivita C, Dal Pan GJ, Sarpatwari A.

Glucagon-Like Peptide-1 Receptor Agonist Order Fills and Out-of-Pocket Costs by Race, Ethnicity, and Indication.

JAMA Health Forum
Sarpatwari A, Soto MJ, Ganguli I, Sloan CE, Goss F, Sinaiko AD.

Glucagon-Like Peptide-1 Receptor Agonist Order Fills and Out-of-Pocket Costs by Race, Ethnicity, and Indication

JAMA Health Forum.
Sarpatwari A, Soto MJ, Ganguli I, Sloan CE, Goss F, Sinaiko AD.

Impact Of Risk Evaluation And Mitigation Strategies On Generic Approvals Of US Pharmaceutical Products.

Health Aff (Millwood)
Kao J, Van de Wiele VL, Beall RF, Sarpatwari A.

Isotretinoin Risk Evaluation and Mitigation Strategy and Pregnancy Incidence.

JAMA Intern Med
Zhu Y, Anand P, Sarpatwari A, Hernández-Díaz S, Bykov K, Kesselheim AS, Avorn J, Vine SM, Adomi M, DiCesare EC, Mahesri M, Zakoul H, Mogun H, Toyserkani GA, LaCivita C, Zhou EH, Dal Pan GJ, Huybrechts KF.

Impact Of Risk Evaluation And Mitigation Strategies On Generic Approvals Of US Pharmaceutical Products

Health Aff (Millwood).
Kao J, Van de Wiele VL, Beall RF, Sarpatwari A.

Isotretinoin Risk Evaluation and Mitigation Strategy and Pregnancy Incidence

JAMA Intern Med.
Zhu Y, Anand P, Sarpatwari A, Hernández-Díaz S, Bykov K, Kesselheim AS, Avorn J, Vine SM, Adomi M, DiCesare EC, Mahesri M, Zakoul H, Mogun H, Toyserkani GA, LaCivita C, Zhou EH, Dal Pan GJ, Huybrechts KF.

Pediatric Exclusivity-Associated Revenues and Labeling Changes, 2013-2023.

J Pediatr
Liu ITT, Raymakers AJN, Sarpatwari A, Kesselheim AS.

Estimating Costs of Market Exclusivity Extensions For 4 Top-Selling Prescription Drugs in the US

JAMA Health Forum.
Hong D, Tu SS, Beall RF, Russo M, Rome BN, Kesselheim AS, Sarpatwari A.

Estimating Costs of Market Exclusivity Extensions For 4 Top-Selling Prescription Drugs in the US.

JAMA Health Forum
Hong D, Tu SS, Beall RF, Russo M, Rome BN, Kesselheim AS, Sarpatwari A.

Legal challenges to the 340B drug pricing program: administration, regulation, and reform.

Health Aff Sch
Knox RP, Sarpatwari A.

State Substitution Laws and Uptake of an Interchangeable Insulin Biosimilar.

JAMA Health Forum
Kwon Y, Sarpatwari A, Dusetzina SB.

Expansion of 340B Disproportionate Share Hospitals in the United States From 2010 to 2022.

Health Serv Res
Liu BY, Russo M, Kesselheim AS, Knox R, Sarpatwari A, Feldman WB.

Physician Experiences With and Perspectives on Clozapine Prescribing.

JAMA Netw Open
Sarpatwari A, Lu Z, Russo M, Zakoul H, Lee SB, Toyserkani GA, Zhou EH, LaCivita C, Hyatt Hawkins Shaw K, Dal Pan GJ, Kesselheim AS.